{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T08:42:07Z","timestamp":1769589727178,"version":"3.49.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.bone.2019.04.014","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T11:44:58Z","timestamp":1556106298000},"page":"103-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Triple-threat activity of PEDF in bone tumors: Tumor inhibition, tissue preservation and cardioprotection against doxorubicin"],"prefix":"10.1016","volume":"124","author":[{"given":"Yongzhong","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Elahy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna M.","family":"Friedhuber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia Y.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery D.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Doschak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crispin R.","family":"Dass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2019.04.014_bb0005","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00402-007-0464-y","article-title":"Prosthetic joint replacement for long bone metastases: analysis of 154 cases","volume":"128","author":"Camnasio","year":"2008","journal-title":"Arch. Orthop. Trauma Surg."},{"key":"10.1016\/j.bone.2019.04.014_bb0010","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00432-012-1367-z","article-title":"Predictors of early distant metastasis in women with breast cancer","volume":"139","author":"Rosa Mendoza","year":"2013","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bone.2019.04.014_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063153","article-title":"RANKL\/RANK\/MMP-1 molecular triad contributes to the metastatic phenotype of breast and prostate cancer cells in vitro","volume":"8","author":"Casimiro","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2019.04.014_bb0020","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1042\/BST0350704","article-title":"Phagocytosis of collagen by fibroblasts and invasive cancer cells is mediated by MT1-MMP","volume":"35","author":"Lee","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bone.2019.04.014_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/jcp.20065","article-title":"MT1-MMP: a tethered collagenase","volume":"200","author":"Holmbeck","year":"2004","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bone.2019.04.014_bb0030","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nm870","article-title":"Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas","volume":"9","author":"Doll","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2019.04.014_bb0035","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nn1657","article-title":"Pigment epithelium-derived factor is a niche signal for neural stem cell renewal","volume":"9","author":"Ramirez-Castillejo","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bone.2019.04.014_bb0040","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/nn.2437","article-title":"Vascular niche factor PEDF modulates notch-dependent stemness in the adult subependymal zone","volume":"12","author":"Andreu-Agullo","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bone.2019.04.014_bb0045","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/bjo.2006.110890","article-title":"Positive correlation between vitreous levels of advanced glycation end products and vascular endothelial growth factor in patients with diabetic retinopathy sufficiently treated with photocoagulation","volume":"91","author":"Yokoi","year":"2007","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.bone.2019.04.014_bb0050","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10585-007-9062-1","article-title":"Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumor activities of pigment epithelium-derived factor","volume":"24","author":"Ek","year":"2007","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.bone.2019.04.014_bb0055","first-page":"382","article-title":"Stimulation of bone regeneration with pigment epithelium-derived factor microparticles: evidence in silico, in vitro and in vivo","volume":"71","author":"Lee","year":"2016","journal-title":"Pharmazie"},{"key":"10.1016\/j.bone.2019.04.014_bb0060","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/nrc3484","article-title":"The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential","volume":"13","author":"Becerra","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bone.2019.04.014_bb0065","doi-asserted-by":"crossref","first-page":"R146","DOI":"10.1186\/bcr3356","article-title":"Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer","volume":"14","author":"Jan","year":"2012","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bone.2019.04.014_bb0070","doi-asserted-by":"crossref","first-page":"45400","DOI":"10.1074\/jbc.M208339200","article-title":"Mapping the type I collagen-binding site on pigment epithelium-derived factor. Implications for its antiangiogenic activity","volume":"277","author":"Meyer","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2019.04.014_bb0075","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/term.1507","article-title":"Glycosaminoglycans enhance osteoblast differentiation of bone marrow derived human mesenchymal stem cells","volume":"8","author":"Mathews","year":"2014","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.bone.2019.04.014_bb0080","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3109\/08977191003604513","article-title":"The applied biochemistry of PEDF and implications for tissue homeostasis","volume":"28","author":"Broadhead","year":"2010","journal-title":"Growth Factors"},{"key":"10.1016\/j.bone.2019.04.014_bb0085","first-page":"1010","article-title":"Reduction in tumour cell invasion by pigment epithelium-derived factor is mediated by membrane type-1 matrix metalloproteinase downregulation","volume":"67","author":"Filiz","year":"2012","journal-title":"Pharmazie"},{"key":"10.1016\/j.bone.2019.04.014_bb0090","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bbrc.2010.05.098","article-title":"Anti-chondrosarcoma effects of PEDF mediated via molecules important to apoptosis, cell cycling, adhesion and invasion","volume":"398","author":"Tan","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2019.04.014_bb0095","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.acthis.2007.12.002","article-title":"Breast adenocarcinoma MCF-7 cell line induces spontaneous osteoclastogenesis via a RANK-ligand-dependent pathway","volume":"110","author":"Nicolin","year":"2008","journal-title":"Acta Histochem."},{"key":"10.1016\/j.bone.2019.04.014_bb0100","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.tem.2011.02.007","article-title":"RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis","volume":"22","author":"Schramek","year":"2011","journal-title":"Tr Endocrinol Metab"},{"key":"10.1016\/j.bone.2019.04.014_bb0105","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.bbrc.2009.11.139","article-title":"PEDF regulates osteoclasts via osteoprotegerin and RANKL","volume":"391","author":"Akiyama","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2019.04.014_bb0110","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/sj.cgt.7701044","article-title":"Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis","volume":"14","author":"Ek","year":"2007","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bone.2019.04.014_bb0115","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/jor.20434","article-title":"PEDF-derived synthetic peptides exhibit antitumor activity in an orthotopic model of human osteosarcoma","volume":"25","author":"Ek","year":"2007","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.bone.2019.04.014_bb0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ijc.24320","article-title":"International OS incidence patterns in children and adolescents, middle ages and elderly persons","volume":"125","author":"Mirabello","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bone.2019.04.014_bb0125","first-page":"11","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bone.2019.04.014_bb0130","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","article-title":"Metastatic behaviour of breast cancer subtypes","volume":"28","author":"Kennecke","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bone.2019.04.014_bb0135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4103\/aja.aja_12_18","article-title":"Bone-targeted therapies to reduce skeletal morbidity in prostate cancer","volume":"20","author":"Dorff","year":"2018","journal-title":"Asian J Androl"},{"key":"10.1016\/j.bone.2019.04.014_bb0140","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/aja.2013.86","article-title":"Interracial differences in prostate cancer progression among patients from the United States, China and Japan","volume":"15","author":"Zhau","year":"2013","journal-title":"Asian J Androl"},{"key":"10.1016\/j.bone.2019.04.014_bb0145","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/annonc\/mdu103","article-title":"Bone health in cancer patients: ESMO clinical practice guidelines","volume":"25","author":"Coleman","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bone.2019.04.014_bb0150","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.7314\/APJCP.2014.15.4.1503","article-title":"Medical treatment of breast cancer bone metastasis: from bisphosphonates to targeted drugs","volume":"15","author":"Erdogan","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.bone.2019.04.014_bb0155","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","article-title":"Breast cancer","volume":"389","author":"Harbeck","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2019.04.014_bb0160","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/bjc.2011.410","article-title":"Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model","volume":"105","author":"Broadhead","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bone.2019.04.014_bb0165","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/jbmr.5650110803","article-title":"Pregnancy and lactation as risk factors for subsequent bone loss and osteoporosis","volume":"11","author":"Sowers","year":"1996","journal-title":"J Bone Mineral Res"},{"key":"10.1016\/j.bone.2019.04.014_bb0170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1475-2867-10-20","article-title":"New clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasis","volume":"10","author":"Clark","year":"2010","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bone.2019.04.014_bb0175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","article-title":"Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems","volume":"65","author":"Tacar","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bone.2019.04.014_bb0180","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/jphp.12539","article-title":"Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism","volume":"68","author":"Meredith","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bone.2019.04.014_bb0190","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2478\/s11658-010-0039-8","article-title":"Identification of molecules derived from human fibroblast feeder cells that support the proliferation of human embryonic stem cells","volume":"16","author":"Anisimov","year":"2011","journal-title":"Cell Mol Biol Lett"},{"key":"10.1016\/j.bone.2019.04.014_bb0195","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/cbin.10041","article-title":"Pigment epithelium-derived factor delays cellular senescence of human mesenchymal stem cells in vitro by reducing oxidative stress","volume":"37","author":"Cao","year":"2013","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.bone.2019.04.014_bb0200","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.285.5425.245","article-title":"Pigment epithelium-derived factor: a potent inhibitor of angiogenesis","volume":"285","author":"Dawson","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bone.2019.04.014_bb0205","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.mpaic.2017.06.021","article-title":"The pancreas","volume":"18","author":"Cade","year":"2017","journal-title":"Anaesthesia and Intensive Care Medicine"},{"key":"10.1016\/j.bone.2019.04.014_bb0210","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.mce.2015.12.010","article-title":"PEDF attenuates insulin-dependent molecular pathways of glucose homeostasis in skeletal myocytes","volume":"422","author":"Carnagarin","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bone.2019.04.014_bb0215","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.mce.2016.02.004","article-title":"Pigment epithelium-derived factor (PEDF) regulates metabolism and insulin secretion from a clonal rat pancreatic beta cell line BRIN-BD11 and mouse islets","volume":"426","author":"Chen","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bone.2019.04.014_bb0220","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1210\/en.2013-1785","article-title":"Pigment epithelium-derived factor (PEDF) suppresses IL-1\u03b2-mediated c-Jun N-terminal kinase (JNK) activation to improve hepatocyte insulin signaling","volume":"155","author":"Gattu","year":"2014","journal-title":"Endocrinolog"},{"key":"10.1016\/j.bone.2019.04.014_bb0225","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.biocel.2016.06.013","article-title":"Pigment epithelium-derived factor stimulates skeletal muscle glycolytic activity through NADPH oxidase-dependent reactive oxygen species production","volume":"78","author":"Carnagarin","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bone.2019.04.014_bb0230","first-page":"7170","article-title":"PEDF regulates lipid metabolism and reduces apoptosis in hypoxic H9c2 cells by inducing autophagy related 5-mediated autophagy via PEDF-R","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bone.2019.04.014_bb0235","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10585-006-9046-6","article-title":"A novel orthotopic murine model provides insights into cellular and molecular characteristics contributing to human osteosarcoma","volume":"23","author":"Dass","year":"2006","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.bone.2019.04.014_bb0240","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000071277","article-title":"Resistance of epiphyseal cartilage to invasion by osteosarcoma is likely to be due to expression of antiangiogenic factors","volume":"70","author":"Quan","year":"2002","journal-title":"Pathobiology"},{"key":"10.1016\/j.bone.2019.04.014_bb0245","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12185-017-2346-6","article-title":"Therapeutic doses of doxorubicin induce premature senescence of human mesenchymal stem cells derived from menstrual blood, bone marrow and adipose tissue","volume":"107","author":"Kozhukharova","year":"2018","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.bone.2019.04.014_bb0250","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1095432","article-title":"The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress","volume":"304","author":"Tinel","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bone.2019.04.014_bb0255","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1091\/mbc.e04-10-0862","article-title":"Doxorubicin requires the sequential activation of caspase-2, protein kinase Cdelta, and c-Jun NH2-terminal kinase to induce apoptosis","volume":"16","author":"Panaretakis","year":"2007","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bone.2019.04.014_bb0260","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.abb.2007.09.007","article-title":"Caspase-2 cleaves DNA fragmentation factor (DFF45)\/inhibitor of caspase-activated DNase (ICAD)","volume":"468","author":"Dahal","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bone.2019.04.014_bb0265","doi-asserted-by":"crossref","first-page":"47477","DOI":"10.1074\/jbc.M307055200","article-title":"Activation of caspases is required for osteoblastic differentiation","volume":"278","author":"Mogi","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2019.04.014_bb0270","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2174\/1389450116666151001112455","article-title":"Alginate bead-encapsulated PEDF induces ectopic bone formation in vivo in the absence of co-administered mesenchymal stem cells","volume":"19","author":"Elahy","year":"2018","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bone.2019.04.014_bb0275","first-page":"47","article-title":"Comparative expression of PEDF and VEGF in human epidermal keratinocytes and dermal fibroblasts: from normal skin to psoriasis","volume":"25","author":"Yan","year":"2018","journal-title":"Discov. Med."},{"key":"10.1016\/j.bone.2019.04.014_bb0280","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/oli.2009.0219","article-title":"Sequence-related off-target effect of Dz13 against human tumor cells and safety in adult and fetal mice following systemic administration","volume":"20","author":"Dass","year":"2010","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.bone.2019.04.014_bb0285","doi-asserted-by":"crossref","first-page":"7828","DOI":"10.1016\/j.biomaterials.2014.05.087","article-title":"The potential role of free chitosan in bone trauma and bone cancer management","volume":"35","author":"Tan","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.bone.2019.04.014_bb0290","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.carbpol.2015.03.018","article-title":"Enhanced anti-tumor effect of pH-responsive dextrin nanogels delivering doxorubicin on colorectal cancer","volume":"126","author":"Manchun","year":"2015","journal-title":"Carbohydr. Polym."},{"issue":"22","key":"10.1016\/j.bone.2019.04.014_bb0295","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10585-006-9004-3","article-title":"Downregulation of uPAR confirms link in growth and metastasis of osteosarcoma","volume":"2005","author":"Dass","year":"2005","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.bone.2019.04.014_bb0300","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1016\/j.biomaterials.2009.03.022","article-title":"A chitosan-dipotassium orthophosphate hydrogel for the delivery of doxorubicin in the treatment of osteosarcoma","volume":"30","author":"Ta","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.bone.2019.04.014_bb0305","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1016\/j.biomaterials.2009.05.035","article-title":"A chitosan hydrogel delivery system for osteosarcoma gene therapy with pigment epithelium-derived factor combined with chemotherapy","volume":"30","author":"Ta","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.bone.2019.04.014_bb0310","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.2042-7158.2012.01572.x","article-title":"Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model","volume":"65","author":"Tan","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bone.2019.04.014_bb0315","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/jphp.12289","article-title":"Pigment epithelium-derived factor upregulates collagen I and downregulates matrix metalloproteinase 2 in osteosarcoma cells, and colocalizes to collagen I and heat shock protein 47 in fetal and adult bone","volume":"66","author":"Alcantara","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bone.2019.04.014_bb0320","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2174\/1389450115666141010150255","article-title":"Systemic delivery of free chitosan accelerates femur fracture healing in rats","volume":"19","author":"Shao","year":"2018","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bone.2019.04.014_bb0325","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.injury.2018.06.040","article-title":"Systemic leptin administration alters callus VEGF levels and enhances bone fracture healing in wildtype and Ob\/Ob mice","volume":"49","author":"Wu","year":"2018","journal-title":"Injury"},{"key":"10.1016\/j.bone.2019.04.014_bb0330","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1211\/jpp.62.04.0009","article-title":"Systemic RANK-fc protein therapy is efficacious against primary osteosarcoma growth in a murine model via activity against osteoclasts","volume":"62","author":"Akiyama","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"issue":"12","key":"10.1016\/j.bone.2019.04.014_bb0335","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1158\/1535-7163.MCT-07-0546","article-title":"Zoledronic acid inhibits osteosarcoma growth in an orthotopic model","author":"Dass","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bone.2019.04.014_bb0340","doi-asserted-by":"crossref","first-page":"9039","DOI":"10.18632\/oncotarget.1996","article-title":"Chemosensitization of solid tumors by inhibition of Bcl-xL expression using DNAzyme","volume":"5","author":"Yu","year":"2014","journal-title":"Oncotarget"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219301504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219301504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:43:39Z","timestamp":1757612619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328219301504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":67,"alternative-id":["S8756328219301504"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2019.04.014","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triple-threat activity of PEDF in bone tumors: Tumor inhibition, tissue preservation and cardioprotection against doxorubicin","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2019.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}